Sheridan Capital closes healthcare Fund IV at $1.1B hard cap
What's the deal? Sheridan Capital PartnersDealroom has a profile for this one. Try Dealroom → has closed its fourth flagship fund at $1.1 billion, hitting its hard cap with institutional commitments. The firm, which invests exclusively in healthcare, said Fund IV was oversubscribed and allocated in under 60 days of launch.
Why now? Fund IV closed at nearly double the size of its $575 million Fund III, drawing both new and existing investors despite what Sheridan called "market challenges." Evercore Private Funds GroupDealroom has a profile for this one. Try Dealroom → served as exclusive fundraising advisor and placement agent.
What's the endgame? The fund targets businesses across healthcare, including outsourced services, products and manufacturing, and patient services. Recent Fund III investments included Carolina Components GroupDealroom has a profile for this one. Try Dealroom →, Tres HealthDealroom has a profile for this one. Try Dealroom →, and Currier PlasticsDealroom has a profile for this one. Try Dealroom →.
Alongside Fund IV, Sheridan closed its Healthcare IT Fund I at $245 million. The vehicle focuses on lower middle market healthcare IT firms in North America and has already backed three platforms: CadaraDealroom has a profile for this one. Try Dealroom →, ICANotesDealroom has a profile for this one. Try Dealroom →, and PtEverywhereDealroom has a profile for this one. Try Dealroom →.
What they said: "With healthcare growing in complexity, business owners and investors recognize the value of a financial partner with specialized expertise," said Jonathan Lewis, co-founder and partner at Sheridan.
Co-founder and partner Sean Dempsey framed the IT fund as an adjacent bet: "We believe healthcare IT remains an underserved segment despite its critical role in improving access, efficiency, and outcomes across the healthcare ecosystem." Harris WilliamsDealroom has a profile for this one. Try Dealroom → acted as placement agent on that fund, and Kirkland & EllisDealroom has a profile for this one. Try Dealroom → served as legal counsel.
The signal: Raising $1.1 billion at hard cap in a tight fundraising market signals sustained investor appetite for specialist healthcare strategies. By pairing its flagship fund with a dedicated IT vehicle, Sheridan is betting on technology as the next fragmented corner of healthcare ripe for consolidation.
Read more: business.theantlersamerican.com
Image credit: Generated with Gemini
